The Russian pharmaceutical industry has recently become the field for serious patent-related battles between large foreign producers of original drugs and Russian manufacturers of generics.

Partner of the Lidings’ Intellectual Property practice Boris Malakhov will take part in the All Russian Conference on Intellectual Property in Pharma Market: Protection of Rights and Court Practice in 2019. Organized by the Agency for Socio-Economic Development the event will take place in Moscow on April 23rd 2019 at the Ararat Park Hyatt Hotel.

Lidings’ Corporate and M&A practice Associate Julia Kuzmenko and Intellectual Property practice Associate Anna Kuminova will speak at the annual conference entitled Pharmaceuticals — 2019: Legal Aspects. The event organized by Pravo.ru will take place in Moscow on April 11th at the Marriott Royal Aurora hotel.

Lidings once again takes top positions as the leading legal advisor in the areas of Dispute Resolution, Corporate and M&A, and Life Sciences in Russia as a result of the best law firms’ research annually conducted by Chambers and Partners Europe.

On December 13, 2018 Russian State Duma has passed in the third reading a draft law empowering the state healthcare control (supervision) body (Roszdravnadzor) to conduct test purchases (“Draft law”).

On November 28, 2018 the Federal law of November 28, 2018 No. 449-FZ “On amendments being made to separate legal acts regarding introduction of drugs into commercial turnover” (the “Law”) was published on the official web portal of legal information.

Lidings, the leading legal advisor in Russia providing legal support to large national and international companies operating in the pharmaceuticals and healthcare sector in Russia and CIS, launces a series of specialized tests on the legislative regulation of the sector.